Last edition
News about "Strides Pharma"
OneSource Secures Equity Commitments of USD 95 Million for Fundraising
The strong interest from leading investors reflects growing confidence in our capabilities and the immense potential of the CDMO sector emerging out of India.
Strides Pharma | 16/10/2024 | By Aishwarya
Strides Gets FDA Approval for Theophylline Extended-Release Tablets
Theophylline Extended-Release Tablets, 300 mg and 450 mg have a combined market size of ~USD 11.5 million, with the 300 mg dosage contributing ~USD 10.8 million.
Strides Pharma | 06/09/2024 | By Aishwarya | 112
Strides Pharma Shows Strong Q1FY25 Results with 16.7 Percent of Revenue Growth
Strides Pharma Science Ltd. has announced its consolidated financial results for the quarter (Q1FY25).
Strides Pharma | 29/07/2024 | By Aishwarya | 105
Strides Pharma Global bags US FDA approval for generic naproxen sodium softgel capsules
The product will be manufactured at the company's Bengaluru facility<br />
Strides Pharma | 22/08/2022 | By Sudeep Soparkar | 337
Glenmark, Strides Pharma, Cipla recalls products in US
The products were recalled due to manufacturing issues
Strides Pharma | 22/08/2022 | By Sudeep Soparkar | 617
Strides Pharma successfully completes US FDA inspection at Singapore facility
The inspection was completed successfully with Zero 483 observations
Strides Pharma | 11/08/2022 | By Sudeep Soparkar | 667
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy